Last updated: 17 June 2024 at 6:51pm EST

Michael Bell Net Worth




The estimated Net Worth of Michael Brian Bell is at least $7.77 Million dollars as of 15 June 2024. Mr. Bell owns over 9,267 units of Caredx Inc stock worth over $619,672 and over the last 8 years he sold CDNA stock worth over $4,794,142. In addition, he makes $2,358,100 as Chief Financial Officer at Caredx Inc.

Mr. Bell CDNA stock SEC Form 4 insiders trading

Michael has made over 19 trades of the Caredx Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently he exercised 9,267 units of CDNA stock worth $264,388 on 15 June 2024.

The largest trade he's ever made was selling 57,136 units of Caredx Inc stock on 6 May 2020 worth over $1,656,944. On average, Michael trades about 5,504 units every 62 days since 2017. As of 15 June 2024 he still owns at least 21,720 units of Caredx Inc stock.

You can see the complete history of Mr. Bell stock trades at the bottom of the page.





Michael Bell biography

Michael Bell is Chief Financial Officer of the Company, effective April 21, 2017. He has over 20 years of international finance and accounting experience. From January 2016 to March 2017, Mr. Bell served as the Chief Financial Officer of Metabiota, Inc., a San Francisco-based company that develops and sells risk analytics products focused on infectious disease. From May 2012 to January 2016, he served as the Chief Financial Officer of Singulex, Inc., a clinical diagnostics company. Prior to that, Mr. Bell held leadership and executive positions within Novartis, including with Novartis Diagnostics, a global provider of blood screening solutions, where he served as Chief Financial Officer from 2011 to 2012, and Senior Director, Global Head of Finance from 2008 to 2011. Mr. Bell also previously worked for several years in public accounting with both Ernst & Young LLP and Deloitte, UK. He holds a Bachelor of Science degree in Mathematics with Computing from the University of Leicester in the United Kingdom, and is a Fellow of the Institute of Chartered Accountants in England & Wales.

What is the salary of Michael Bell?

As the Chief Financial Officer of Caredx Inc, the total compensation of Michael Bell at Caredx Inc is $2,358,100. There are 1 executives at Caredx Inc getting paid more, with Peter Maag having the highest compensation of $8,855,740.



How old is Michael Bell?

Michael Bell is 51, he's been the Chief Financial Officer of Caredx Inc since 2017. There are 8 older and 8 younger executives at Caredx Inc. The oldest executive at Caredx Inc is Ralph Snyderman, 80, who is the Independent Director.

What's Michael Bell's mailing address?

Michael's mailing address filed with the SEC is 3100, Hanover Street, Palo Alto, Santa Clara County, California, 94306, United States.

Insiders trading at Caredx Inc

Over the last 10 years, insiders at Caredx Inc have traded over $60,271,359 worth of Caredx Inc stock and bought 1,726,634 units worth $9,072,700 . The most active insiders traders include Group Holdings (Sbs) Adviso..., Neil Gagnon, and Peter Maag. On average, Caredx Inc executives and independent directors trade stock every 17 days with the average trade being worth of $615,506. The most recent stock trade was executed by Alexander L Johnson on 20 August 2024, trading 61,023 units of CDNA stock currently worth $1,432,820.



What does Caredx Inc do?

caredx: transforming transplant patient care through novel surveillance management solutions caredx, inc. is dedicated to improving the lives of organ transplant patients through non-invasive diagnostics. by combining the latest advances in genomics and bioinformatics technology, with a commitment to generating high quality clinical evidence through trials and registries, caredx is at the forefront of organ transplant surveillance and pre-transplant hla typing solutions. nasdaq:cdna about allosure® allosure is the first and only non-invasive blood test that directly measures allograft injury and identifies the probability of active rejection to better manage kidney transplant patients. allosure is a clinical-grade, proprietary next-generation sequencing (ngs) based test to detect donor-derived cell-free dna (dd-cfdna) in order to identify organ injury in kidney transplant recipients. allosure is analytically validated as a sensitive, specific, and precise measurement of dd-cfdna. allos



What does Caredx Inc's logo look like?

Caredx Inc logo

Complete history of Mr. Bell stock trades at Caredx Inc and Guardant Health Inc

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
15 Jun 2024 Michael Brian Bell
Chief Financial Officer
Option 9,267 $30.21 $279,956
15 Jun 2024
21,720
15 Mar 2024 Michael Brian Bell
Chief Financial Officer
Option 1,233 $17.74 $21,873
15 Mar 2024
12,882
15 Jan 2024 Michael Brian Bell
Chief Financial Officer
Option 3,308 $24.20 $80,054
15 Jan 2024
13,005
15 Dec 2023 Michael Brian Bell
Chief Financial Officer
Option 1,233 $28.19 $34,758
15 Dec 2023
10,124
15 Sep 2023 Michael Brian Bell
Chief Financial Officer
Option 1,233 $29.53 $36,410
15 Sep 2023
9,318
15 Jun 2023 Michael Brian Bell
Chief Financial Officer
Option 1,233 $37.86 $46,681
15 Jun 2023
8,512
15 Mar 2023 Michael Brian Bell
Chief Financial Officer
Option 4,931 $26.78 $132,052
15 Mar 2023
8,982
15 Jan 2023 Michael Brian Bell
Chief Financial Officer
Option 3,309 $30.43 $100,693
15 Jan 2023
5,371
3 Nov 2020 Michael Brian Bell
Chief Financial Officer
Sale 32,574 $48.15 $1,568,438
3 Nov 2020
103,343
6 May 2020 Michael Brian Bell
Chief Financial Officer
Sale 57,136 $29.00 $1,656,944
6 May 2020
77,093
20 Jun 2019 Michael Brian Bell
Chief Financial Officer
Option 14,702 $10.99 $161,575
20 Jun 2019
85,602
20 May 2019 Michael Brian Bell
Chief Financial Officer
Option 2,202 $3.91 $8,610
20 May 2019
79,299
9 May 2019 Michael Brian Bell
Chief Financial Officer
Sale 14,894 $32.42 $482,863
9 May 2019
77,097
1 Mar 2019 Michael Brian Bell
Chief Financial Officer
Sale 13,000 $31.36 $407,680
1 Mar 2019
77,290
20 Feb 2019 Michael Brian Bell
Chief Financial Officer
Sale 2,200 $26.30 $57,860
20 Feb 2019
77,060
15 Feb 2019 Michael Brian Bell
Chief Financial Officer
Option 28,122 $4.45 $125,143
15 Feb 2019
105,320
13 Sep 2018 Michael Brian Bell
Chief Financial Officer
Sale 16,355 $25.06 $409,856
13 Sep 2018
52,238
14 Aug 2018 Michael Brian Bell
Chief Financial Officer
Sale 12,500 $16.84 $210,500
14 Aug 2018
68,593
15 Aug 2017 Michael Brian Bell
Chief Financial Officer
Buy 725 $1.83 $1,327
15 Aug 2017
725


Caredx Inc executives and stock owners

Caredx Inc executives and other stock owners filed with the SEC include: